losartan has been researched along with Extravasation of Contrast Media in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with losartan attenuated the N(omega)-nitro-L-arginine methyl ester (L-NAME)-induced increase in total peripheral resistance by 26% and also blunted the fall in CI (28%) and stroke volume." | 1.30 | Role of angiotensin II in modulating the hemodynamic effects of nitric oxide synthesis inhibition. ( Carbonell, LF; Fenoy, FJ; Hernández, I; Quesada, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández, I | 1 |
| Carbonell, LF | 1 |
| Quesada, T | 1 |
| Fenoy, FJ | 1 |
1 other study available for losartan and Extravasation of Contrast Media
| Article | Year |
|---|---|
Role of angiotensin II in modulating the hemodynamic effects of nitric oxide synthesis inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Capillary Permeability; Enzyme Inhibitors | 1999 |